<?xml version="1.0" encoding="UTF-8"?>
<p>Overall, LRRK2 mutations account for 5 – 15% of dominant familial [
 <xref rid="r11" ref-type="bibr">11</xref>], and 1– 3% of sporadic PD cases [
 <xref rid="r12" ref-type="bibr">12</xref>], whilst another mutation, the R1441G variant, is a Basque founder mutation with a prevalence of 15% in patients with PD from this region [
 <xref rid="r13" ref-type="bibr">13, 14</xref>].
</p>
